Navigating Clinical Trials at UC Davis (2012)
Five Modules, all from 1 pm-2:30 pm
March 20, March 23, March 27, April 3, April 13 [date change] @ PSSB Building, Room G300
Participants need to sign up for individual modules.
Reading Materials: Clinical Trials Process Maps and SOPs http://intranet.ucdmc.ucdavis.edu/ctsc/area/clinicaltrials/processmaps.shtml
Archived 2011 Navigation Course can be found at:
Purpose: this training focuses on the operational flow of clinical research at UC Davis. After taking this course, the participants should fully understand the sequence of events, responsible parties and administrative requirements. Completion of this course ensures a better comprehension of the steps required for initiation and completion of a clinical study. Investigator-initiated and industry-initiated studies will be addressed.
Recommended: particularly useful for new faculty and staff embarking on clinical research path, including Principal Investigators, Residents, Fellows, Co-Investigators, Sub-Investigators, Clinical Research Coordinators, Research Nurse Coordinators, Jr. Specialists, and Research Administrative Staff.
03/20/2012 Module 1. IRB, ClinicalTrials.gov, regulatory documentation
03/23/2012 Module 2. Coverage analysis
03/27/2012 Module 3. Investigational Drugs Serices (management and accountability) 04/03/2012 Module 4. Budgeting and Contracts for Industry Trials
04/13/2012 [date change] Module 5. Tracking subjects through Invision/EMR to generate correct billing
Questions? Contact Kate Marusina, Manager, Clinical Trials Resource Group, Kate.Marusina@ucdmc.ucdavis.edu
University of California, Davis, Clinical and Translational Sciences Center
About CTSC Clinical Trials Resource Group
We provide broad range of support services to the UC Davis Research Community, streamlining the path to regulatory approval of human subject protocols and maintaining the regulatory compliance for the duration of the study.
Services We Offer
1. Logistical support to clinical research protocols
2. Education and training of investigators and staff
3. Clinical trials monitoring